Cancer News and Research

Latest Cancer News and Research

Weight loss, combined with vitamin D supplements, reduces chronic inflammation

For the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone. Chronic inflammation is known to contribute to the development and progression of several diseases, including some cancers.

26 Jun 2015

QUT researcher reveals how compulsive snacking can be a major cause of weight gain

A QUT researcher has had an article on how compulsive snacking is a major cause of weight gain published in the international journal Eating Behaviors.

26 Jun 2015

Alabama scientists show how phytochemical in magnolia works against head and neck cancers

Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?

26 Jun 2015

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

Investigators from Dartmouth's Norris Cotton Cancer Center harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.

25 Jun 2015

Open windows can be extremely dangerous for young children

The dog days of summer are here. But as we try to catch a cool breeze, that open window can become a dangerous hazard for children. In fact, emergency rooms treat more than 5,000 children each year for injuries related to falls from windows.

25 Jun 2015

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris Inc. announced today that it has executed a definitive agreement with Ergomed PLC, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD").

25 Jun 2015

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.

25 Jun 2015

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market on June 29, 2015 under the symbol CXRX.

25 Jun 2015

UAlberta partnership could transform cancer treatment, improve patient outcomes

A multimillion dollar research partnership announced today at the University of Alberta is giving a "dream team" of researchers the opportunity to potentially transform cancer treatment and better patient outcomes.

25 Jun 2015

Weight loss along with vitamin D supplementation reduces chronic inflammation

25 Jun 2015

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Siemens and BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, have entered into a strategic collaboration.

25 Jun 2015

Pan Am Cancer Treatment Center announces publication of immuno-oncology text book

The Pan Am Cancer Treatment Center is pleased to announce the publication of a specialized textbook titled "Immuno-Oncology, from Bench to Bedside" which provides scientific rationale for the use of immunotherapy in the treatment of cancer.

25 Jun 2015

Detroit-area patients contribute to national study that redefines diagnosis, treatment of glioma

Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified - and ultimately treated.

25 Jun 2015

The Volunteer Center honors McKesson with 2015 Corporate Community Involvement Award

As part of its annual Bay Area Volunteer Awards, The Volunteer Center has named McKesson the recipient of its 2015 Corporate Community Involvement Award.

25 Jun 2015

Current tobacco control policies are softening the smoking population, shows UCSF study

Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are "unable or unwilling to quit."

25 Jun 2015

STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

Many patients with advanced cancers experience significant pain, and the pain caused by metastases (cancers that have spread to the spine) can be excruciating as tumor growth replaces bone.

25 Jun 2015

New method could help identify 'handedness' of different molecules in mixture

Scientists have demonstrated for the first time the ability to rapidly, reliably and simultaneously identify the 'handedness' of different molecules in a mixture.

25 Jun 2015

Despite FDA ban, flavored cigarettes still available for purchase over the Internet

Think clove cigarettes are so six years ago? A new study from Keck School of Medicine of the University of Southern California (USC) researchers finds that despite a federal Food and Drug Administration (FDA) ban in 2009, flavored cigarettes are still available for purchase over the Internet and are popular search targets.

25 Jun 2015

Researchers develop protective vaccine against chlamydia infections

Chlamydiae are the most common, sexually transmitted, bacterial pathogens in the world. Every year around 100 million people contract Chlamydia infections, which are one of the main causes of female infertility and ectopic pregnancies and can also lead to blindness - especially in developing countries.

25 Jun 2015

Myriad Genetics, Chris4Life launch educational campaign to teach individuals about risk of hereditary cancer

Chris4Life Colon Cancer Foundation, a Washington, D.C.-based national non-profit organization, and Myriad Genetics, a leader in personalized medicine, today announced their “What’s Your History” family history week (June 24-30, 2015).

25 Jun 2015

Cancer News and Research

Latest Cancer News and Research

Weight loss, combined with vitamin D supplements, reduces chronic inflammation

QUT researcher reveals how compulsive snacking can be a major cause of weight gain

Alabama scientists show how phytochemical in magnolia works against head and neck cancers

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

Open windows can be extremely dangerous for young children

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

UAlberta partnership could transform cancer treatment, improve patient outcomes

Weight loss along with vitamin D supplementation reduces chronic inflammation

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Pan Am Cancer Treatment Center announces publication of immuno-oncology text book

Detroit-area patients contribute to national study that redefines diagnosis, treatment of glioma

The Volunteer Center honors McKesson with 2015 Corporate Community Involvement Award

Current tobacco control policies are softening the smoking population, shows UCSF study

STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

New method could help identify 'handedness' of different molecules in mixture

Despite FDA ban, flavored cigarettes still available for purchase over the Internet

Researchers develop protective vaccine against chlamydia infections

Myriad Genetics, Chris4Life launch educational campaign to teach individuals about risk of hereditary cancer

Understanding the DNA Damage Response in Innate Immunity eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Newsletters you may be interested in